MPO has been a target for several neurological disorders, with inhibition showing beneficial outcomes in Parkinson’s disease (PD) and AD patients, and in murine stroke or atherosclerosis models [29,30,31,32], whereas in an animal model for multiple sclerosis (MS), the presence of MPO seems to have a protective function [33]. The gene discussed is MPO; the disease is myeloid sarcoma.